Huaheng Biotech: Plans to issue no more than 31.9593 million overseas-listed ordinary shares

Huaheng Biologicals Co., Ltd. announced that the company recently received the “Overseas Issuance and Listing Filing Notice” issued by the China Securities Regulatory Commission, titled “Regarding the Filing Notice for the Overseas Offering and Listing of Anhui Huaheng Biotechnology Co., Ltd.” The company plans to issue no more than 31.95 million overseas listed ordinary shares and list them on the Main Board of the Hong Kong Stock Exchange.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin